The effect of cardiac shock wave therapy on myocardial function and perfusion in the randomized, triple-blind, sham-procedure controlled study.

Journal Information

Full Title: Cardiovasc Ultrasound

Abbreviation: Cardiovasc Ultrasound

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests GB has received investigator fees from Sanofi, Janssen Research, and Daichii Sankyo; has received research support from Medispec (applicators for this study). ES has received consulting fee and research support from Medispec (applicators for this study); has received investigator fees from Servier and Bayer. GZ has received research support from Medispec for Cardiac Shock wave study. BP is a member of steering committee for Novartis and Janssen Research; has received speaker fees from Remedica, Astra Zeneca, Pfizer, Bayer and Boehringer -Ingelheim. JC is a member of advisory board for Novartis; has received investigator fees from Amgen, Sanofi and Servier; has received research support from Medispec (applicators for this study). GJ, DV, KČ, RK, IB, RS, JM, and AL have no competing interest."

Evidence found in paper:

"Funding Not applicable."

Evidence found in paper:

"Trial registration Clinicaltrials.gov (NCT02339454). The trial was registered retrospectively on 12 January 2015."

Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025